Intermediates
2-(4-ethoxybenzyl)-4-bromo-1-chlorobenzene
Mol. Wt.: 325.63
(5-bromo-2-chlorophenyl)(4-ethoxyphenyl)methanone
Mol. Wt.: 339.61
[3-(Trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine Hydrochloride]
Mol. Wt.: 228.6
(2-Chloro-5-iodophenyl)(4-
fluorophenyl)methanone
Mol. Wt.: 360.55
Under Development
2-(4-ethoxybenzyl)-1-chloro-4-iodobenzene
Mol. Wt.: 372.63
(2-chloro-5-iodophenyl)(4-ethoxyphenyl)methanone
Mol. Wt.: 386.61
Under Development
2-(5-iodo-2-methylbenzyl)-5-(4-fluorophenyl)thiophene
Mol. Wt.: 408.27
Slide For More
Sl. | Product Name | Structure | Molecule details | Cas. No. | Remarks/Uses | Specification | Status |
1 | 2-(4-ethoxybenzyl)-4-bromo-1-chlorobenzene |  | M.F.: C15H14BrClO | 461432-23-5 | Key starting material for the preparation of Dapagliflozin | In-house | Commercial |
2 | (5-bromo-2-chlorophenyl)(4-ethoxyphenyl)methanone |  | M.F.: C15H12BrClO2 | 461432-22-4 | Key starting material for the preparation of Dapagliflozin | In-house | Commercial |
3 | [3-(Trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine Hydrochloride] |  | M.F.: C6H8ClF3N4 | 762240-92-6 | It’s an sitagliptin pharmaceutical intermediate for the preparation of Sitagliptin phosphate | In-house | Commercial |
4 | (2-Chloro-5-iodophenyl)(4- |  | M.F.: C13H7ClFIO | 915095-86-2 | Key starting material for the preparation of Empagliflozin | - | Under Development |
5 | 2-(4-ethoxybenzyl)-1-chloro-4-iodobenzene |  | M.F.: C15H14ClIO | 1103738-29-9 | Key starting material for the preparation of Dapagliflozin | - | Under Development |
6 | (2-chloro-5-iodophenyl)(4-ethoxyphenyl)methanone |  | M.F.: C15H12ClIO2 | 1103738-26-6 | Key starting material for the preparation of Dapagliflozin | - | Under Development |
7 | 2-(5-iodo-2-methylbenzyl)-5-(4-fluorophenyl)thiophene |  | M.F.:C18H14FIS | 898566-17-1 | Key starting material for the preparation of Canagliflozin | - | Under Development |
2-(4-ethoxybenzyl)-4-bromo-1-chlorobenzene
M.F.: C15H14BrClO
Mol. Wt.: 325.63
461432-23-5
Key starting material for the preparation of Dapagliflozin
Complete
(5-bromo-2-chlorophenyl)(4-ethoxyphenyl)methanone
M.F.: C15H12BrClO2
Mol. Wt.: 339.61
461432-22-4
Key starting material for the preparation of Dapagliflozin
Complete
[3-(Trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine Hydrochloride]
M.F.: C6H8ClF3N4
Mol. Wt.: 228.6
762240-92-6
It’s an sitagliptin pharmaceutical intermediate for the preparation of Sitagliptin phosphate
Complete
(2-Chloro-5-iodophenyl)(4-fluorophenyl)methanone
M.F.: C13H7ClFIO
Mol. Wt.: 360.55
915095-86-2
Key starting material for the preparation of Empagliflozin
Under Development
2-(4-ethoxybenzyl)-1-chloro-4-iodobenzene
M.F.: C15H14ClIO
Mol. Wt.: 372.63
1103738-29-9
Key starting material for the preparation of Dapagliflozin
Under Development
(2-chloro-5-iodophenyl)(4-ethoxyphenyl)methanone
M.F.: C15H12ClIO2
Mol. Wt.: 386.61
1103738-26-6
Key starting material for the preparation of Dapagliflozin
Under Development
2-(5-iodo-2-methylbenzyl)-5-(4-fluorophenyl)thiophene
M.F.:C18H14FIS
Mol. Wt.: 408.27
898566-17-1
Key starting material for the preparation of Canagliflozin
Under Development
2-(4-ethoxybenzyl)-4-bromo-1-chlorobenzene
Mol. Wt.: 325.63
461432-23-5
Key starting material for the preparation of Dapagliflozin
Complete
(5-bromo-2-chlorophenyl)(4-ethoxyphenyl)methanone
Mol. Wt.: 339.61
Complete
[3-(Trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine Hydrochloride]
Mol. Wt.: 339.61
Complete
(2-Chloro-5-iodophenyl)(4-fluorophenyl)methanone
Mol. Wt.: 360.55
915095-86-2
Under Development
2-(4-ethoxybenzyl)-1-chloro-4-iodobenzene
Mol. Wt.: 372.63
Under Development
(2-chloro-5-iodophenyl)(4-ethoxyphenyl)methanone
1103738-26-6
Under Development
2-(5-iodo-2-methylbenzyl)-5-(4-fluorophenyl)thiophene
Mol. Wt.: 408.27
Under Development
